Johnson & Johnson Vision announced today that it launched its Acuvue Abiliti overnight lens as well as a new intraocular lens.
The FDA approved an expanded range of the Acuvue Abiliti overnight therapeutic lenses for myopia management. Approval covers lenses up to six diopters, widening the range from the previously approved four diopters.
Abiliti overnight lenses, orthokeratology (ortho-k) lenses, temporarily reduce refractive error. Subject to a professional myopia management plan, the lenses may eliminate the need to wear contacts or glasses during waking hours after removal. According to a news release, Johnson & Johnson Vision designed them to match a patient’s eye based on corneal shape and prescription.
J&J Vision features in MassDevice’s 5 top ophthalmic device innovations you need to know. READ HERE
The offering features FitAbility software to guide professionals through the fitting proc…